• MS analysis of biologically active substances 'requires depletion of abundant proteins'
    Biologically active substances may need to undergo immunodepletion to facilitate analysis

Bioanalytical

MS analysis of biologically active substances 'requires depletion of abundant proteins'

Dec 15 2010

Analysing biologically active substances to determine the factors that play a role in wound healing requires more abundant proteins to be depleted in the tissue sample, suggest researchers.

In an article published in BMC Research Notes, a journal specialising in updated findings and data sets, scientists at Ruhr-University Bochum in Germany explain that depleting the most abundant proteins is "inevitable".

This is because they would otherwise mask the lesser abundant proteins in mass spectrometric analysis, preventing the biologically active substances from being investigated.

Using a commercially available kit for immunodepletion of abundant proteins, the team were able to raise relative levels of the less apparent genetic sequences by five or six times.

This allows fluids obtained from healing wounds to be investigated in order to decide whether chronic illnesses - like diabetes - might hamper the recovery process.

According to the scientists, the use of the immunodepletion kit represents "a first but important step" in this analysis process.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

analytica 2024

Apr 09 2024 Munich, Germany

Korea Lab 2024

Apr 23 2024 Kintex, South Korea

Korea Chem 2024

Apr 23 2024 Seoul, South Korea

AOCS Annual Meeting & Expo

Apr 28 2024 Montreal, Quebec, Canada

SETAC Europe

May 05 2024 Seville, Spain

View all events